Sunday, May 04, 2025

 

The all-female Korean Haenyeo divers show genetic adaptions to cold water diving



Cell Press
Group of Haenyeo divers on a rocky shore 

image: 

A group of Haenyeo divers in Jeju, Korea.

view more 

Credit: Melissa Ilardo




The Haenyeo, a group of all-female divers from the Korean island of Jeju, are renowned for their ability to dive in frigid waters without the aid of breathing equipment — even while pregnant. A study publishing on May 2 in the Cell Press journal Cell Reports shows that the divers’ remarkable abilities are due to both training and genetic adaptation, including gene variants associated with cold tolerance and decreased blood pressure. The divers also showed pronounced bradycardia, or slowing of the heart rate, when they dived, but this trait is likely due to a lifetime of training, not genetics.  

“The Haenyeo are amazing, and their incredible ability is written in their genes,” says geneticist Melissa Ilardo of the University of Utah. “The fact that women are diving through their pregnancy, which is a really tough thing to do, has actually influenced an entire island’s people.”  

The Haenyeo, or “women of the sea,” dive year-round in social collectives to harvest food for their communities. They begin training at around age ten and continue for their whole lives. Inspired by the Haenyeo’s remarkable diving abilities, the researchers wanted to know whether they have distinguishable physiological traits that help them cope with the strain of diving, and if so, whether these traits are due to genetic adaptation or training. 

To find out, the team compared the physiological traits and genomes of 30 Haenyeo divers to 30 non-Haenyeo people from Jeju, as well as 31 people from mainland Korea. To match the age of the divers, the average age of all participants was 65. The researchers compared the participants’ heart rate and blood pressure at rest and during “simulated dives” where the participants held their breath while submerging their faces in cold water.  

“If you hold your breath and put your face in a bowl full of cold water, your body responds as if you’re diving,” says Ilardo. “A lot of the same processes happen in your body that would happen if you were to jump in the ocean, but it’s done in a way that’s safe for people with no diving experience.” 

The team’s genomic analysis showed that Jeju residents — both Haenyeo and non-Haenyeo — were distinct from individuals from mainland Korea, suggesting that all Jeju residents are descended from the same ancestral population.  

“We can essentially think of everyone from Jeju as either ‘diving Haenyeo’ or ‘non-diving Haenyeo,’ because their genetics are the same,” says Ilardo.  

The genomic analysis also revealed two gene variants in the Haenyeo that may help them cope with the pressures of diving, making the Haenyeo the second known population of traditional breath-hold divers that has evolved for diving. One gene is associated with cold tolerance, which could make the divers less vulnerable to hypothermia. The other gene is associated with decreased diastolic blood pressure (i.e., blood pressure in between heart contractions). The variant was found in 33% of participants from Jeju but only 7% of mainland participants. 

“This association may reflect natural selection to mitigate the complications of diastolic hypertension experienced by female divers while diving through pregnancy,” says Ilardo. “Since Bajau women also dive while they’re pregnant, we wonder whether pregnancy is actually driving a lot of the genetic changes in these diving populations.” 

During the simulated dives, all of the participants showed decreased heart rates, but the Haenyeo’s heart rates dropped significantly more than those of either control group. On average, the divers’ heart rates decreased by 18.8 beats per minute (bpm) compared to a decrease of 12.6 bpm in the Jeju non-divers. A lowered heart rate during diving is beneficial because it saves energy and conserves oxygen. Since their genomic analysis indicated that Haenyeo and non-diving Jeju are genetically members of the same population, the researchers concluded that this feature is likely due to the divers’ training. 

“Because the Haenyeo have been diving for a very long time, their heart rate has been trained to drop more,” says Ilardo. “This was something we could actually visually see — we had one diver whose heart rate dropped by over 40 beats per minute in less than 15 seconds.” 

The researchers say that these findings highlight the potential of studying traditional diving populations to better understand human genetic and physiological adaptation.  

“We’re really excited to learn more about how these genetic changes may be affecting the health of the broader population of Jeju,” says Ilardo. “If we can more deeply characterize how those changes affect physiology, it could inspire the development of therapeutics to treat different conditions, such as hypertensive disorders of pregnancy and stroke.” 

### 

This research was supported by the Office of Naval Research, the National Institutes of Health, and the National Science Foundation. 

Cell Reports, Aguilar-Gómez et al., “Genetic and training adaptations in the Haenyeo divers of Jeju, Korea.” https://www.cell.com/cell-reports/fulltext/S2211-1247(25)00348-1

Cell Reports (@CellReports), published by Cell Press, is a weekly open-access journal that publishes high-quality papers across the entire life sciences spectrum. The journal features reports, articles, and resources that provide new biological insights, are thought-provoking, and/or are examples of cutting-edge research. Visit http://www.cell.com/cell-reports. To receive Cell Press media alerts, contact press@cell.com.   

A Haenyeo diver carries a net full of seafood on her back while walking along a rocky shoreline in Jeju, Korea.

Haenyeo divers on a fishing boat off the coast of Jeju, Korea preparing for a dive.

Credit

Ho-Joon Lee

 

Antivenom neutralizes the neurotoxins of 19 of the world’s deadliest snakes


Cell Press
Snake venom protection by a cocktail of varespladib and broadly neutralizing human antibodies 

image: 

Graphical abstract

view more 

Credit: Glanville et al. / Cell





By using antibodies from a human donor with a self-induced hyper-immunity to snake venom, scientists have developed the most broadly effective antivenom to date, which is protective against the likes of the black mamba, king cobra, and tiger snakes in mouse trials. Described May 2 in the Cell Press journal Cell, the antivenom combines protective antibodies and a small molecule inhibitor and opens a path toward a universal antiserum.

How we make antivenom has not changed much over the past century. Typically, it involves immunizing horses or sheep with venom from single snake species and collecting the antibodies produced. While effective, this process could result in adverse reactions to the non-human antibodies, and treatments tend to be species and region-specific.

While exploring ways to improve this process, scientists stumbled upon someone hyper-immune to the effects of snake neurotoxins. “The donor, for a period of nearly 18 years, had undertaken hundreds of bites and self-immunizations with escalating doses from 16 species of very lethal snakes that would normally a kill a horse,” says first author Jacob Glanville, CEO of Centivax, Inc.

After the donor, Tim Friede, agreed to participate in the study, researchers found that by exposing himself to the venom of various snakes over several years, he had generated antibodies that were effective against several snake neurotoxins at once.

“What was exciting about the donor was his once-in-a-lifetime unique immune history,” says Glanville. “Not only did he potentially create these broadly neutralizing antibodies, in this case, it could give rise to a broad-spectrum or universal antivenom.”

To build the antivenom, the team first created a testing panel with 19 of the World Health Organization’s category 1 and 2 deadliest snakes across the elapid family, a group which contains roughly half of all venomous species, including coral snakes, mambas, cobras, taipans, and kraits. Next, researchers isolated target antibodies from the donor’s blood that reacted with neurotoxins found within the snake species tested. One by one, the antibodies were tested in mice envenomated from each species included in the panel. In this way, scientists could systematically build a cocktail comprising a minimum but sufficient number of components to render all the venoms ineffective. 

The team formulated a mixture comprising three major components: two antibodies isolated from the donor and a small molecule. The first donor antibody, called LNX-D09, protected mice from a lethal dose of whole venom from six of the snake species present in the panel. To strengthen the antiserum further, the team added the small molecule varespladib, a known toxin inhibitor, which granted protection against an additional three species. Finally, they added a second antibody isolated from the donor, called SNX-B03, which extended protection across the full panel.

“By the time we reached 3 components, we had a dramatically unparalleled breadth of full protection for 13 of the 19 species and then partial protection for the remaining that we looked at,” says Glanville. “We were looking down at our list and thought, ‘what’s that fourth agent’? And if we could neutralize that, do we get further protection?” Even without a fourth agent, their results suggest that the three-part cocktail could be effective against many other, if not most, elapid snakes not tested in this study.

With the antivenom cocktail proving effective in mouse models, the team now looks to test its efficacy out in the field, beginning by providing the antivenom to dogs brought into veterinary clinics for snake bites in Australia. Further, they wish to develop an antivenom targeting the other major snake family, the vipers.

“We’re turning the crank now, setting up reagents to go through this iterative process of saying what’s the minimum sufficient cocktail to provide broad protection against venom from the viperids,” says lead author Peter Kwong, Richard J. Stock professor of medical sciences at Columbia University Vagelos College of Physicians and Surgeons and formerly of the National Institutes of Health. “The final contemplated product would be a single, pan-antivenom cocktail or we potentially would make two: one that is for the elapids and another that is for the viperids because some areas of the world only have one or the other.”

The other major goal is to approach philanthropic foundations, governments, and pharmaceutical companies to support the manufacturing and clinical development of the broad-spectrum antivenom. “This is critical, because although there are millions of snake envenomations per year, the majority of those are in the developing world, disproportionately affecting rural communities,” Glanville says.

###

This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health, the National Institutes of Health Small Business Innovation Research program, and the US Department of Energy.

Cell, Glanville et al.: “Snake-venom protection by a cocktail of varespladib and broadly neutralizing human antibodies” https://www.cell.com/cell/fulltext/S0092-8674(25)00402-7

Cell (@CellCellPress), the flagship journal of Cell Press, is a bimonthly journal that publishes findings of unusual significance in any area of experimental biology, including but not limited to cell biology, molecular biology, neuroscience, immunology, virology and microbiology, cancer, human genetics, systems biology, signaling, and disease mechanisms and therapeutics. Visit: http://www.cell.com/cell. To receive Cell Press media alerts, contact press@cell.com

 

Postpartum care differences in LGBTQ+ and non-LGBTQ+ individuals



JAMA Health Forum



About The Study: Despite similar access to health insurance, lesbian, gay, bisexual, transgender, queer, and other sexual and gender minority (LGBTQ+) people had large inequities in unmet health care needs and cost-related medication nonadherence in the postpartum year. Results suggested LGBTQ+ people receive lower-quality care in the postpartum period. Although use of pregnancy-related care was comparable, LGBTQ+ individuals used more primary and specialist care and were nearly twice as likely to use the emergency department compared with non-LGBTQ+ people.

Corresponding Author: To contact the corresponding author, Kevin H. Nguyen, PhD, email nguyen@bu.edu.

To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/

(doi:10.1001/jamahealthforum.2025.0672)

Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

 https://jamanetwork.com/journals/jama-health-forum/fullarticle/10.1001/jamahealthforum.2025.0672?utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_term=050225